Human immune response to the 18-kDa outer-membrane antigen of Vibrio cholerae

References

1. Cash RA, Music SI, Libonati JP, Craig JP, Pierce NF, Homick RB. Response of man to infection with Vibrio cholerae. II. Protection from illness afforded by previous disease and vaccine. J Infect Dis 1974; 130:325–333
   [Google Scholar]
2. Clements ML, Levine MM, Young CR et al. Magnitude, kinetics, and duration of vibriocidal antibody responses in North Americans after ingestion of Vibrio cholerae. J Infect Dis 1982; 145:465–473
   [Google Scholar]
3. Kaper JB, Lockman H, Baldini MM, Levine MM. Recombinant nontoxinogenic Vibrio cholerae strains as attenuated cholera vaccine candidates. Nature 1984; 308:655–658
   [Google Scholar]
4. Levine MM, Nalin DR, Craig JP et al. Immunity of cholera in man: relative role of antibacterial versus antitoxic immunity. Trans R Soc Trop MedHyg 1979; 73:3–9
   [Google Scholar]
5. Levine MM, Black RE, Clements ML et al. Evaluation in humans of attenuated Vibrio cholerae El Tor Ogawa strain Texas Star-SR as a live oral vaccine. Infect Immun 1984; 43:515–522
   [Google Scholar]
6. Levine MM, Kaper JB, Herrington D et al. Volunteer studies of deletion mutants of Vibrio cholerae 01 prepared by recombinant techniques. Infect Immun 1988; 56:161–167
   [Google Scholar]
7. Levine MM, Herrington D, Losonsky G et al. Safety, immuno-genicity, and efficacy of recombinant live oral cholera vaccines, CVD 103 and CVD 103-HgR. Lancet 1988; 2:467–470
   [Google Scholar]
8. Migasena S, Pitisuttitham P, Prayurahong B et al. Preliminary assessment of the safety and immunogenicity of live oral cholera vaccine strain CVD 103-HgR in healthy Thai adults. Infect Immun 1989; 57:3261–3264
   [Google Scholar]
9. Sciortino CV, Yang Z, Finkelstein RA. Monoclonal antibodies to outer membrane antigens of Vibrio cholerae. Infect Immun 1985; 49:122–131
   [Google Scholar]
10. Sciortino CV. Protection against infection with Vibrio cholerae by passive transfer of monoclonal antibodies to outer membrane antigens. J Infect Dis 1989; 160:248–252
    [Google Scholar]
11. Holmes RK, Vasil ML, Finkelstein RA. Studies on toxigenesis in Vibrio cholerae. III. Characterization of non-toxinogenic mutants in vitro and in experimental animals. J Clin Invest 1975; 55:551–560
    [Google Scholar]
12. Sigel SP, Payne SM. Effect of iron limitation on growth, siderophore production, and expression of outer membrane proteins of Vibrio cholerae. J Bacteriol 1982; 150:148–155
    [Google Scholar]
13. Filip C, Fletcher G, WulfT JL, Earhart CF. Solubilization of the cytoplasmic membrane of Escherichia coli by the ionic detergent sodium-lauryl sarcosinate. J Bacteriol 1973; 115:717–722
    [Google Scholar]
14. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193:265–275
    [Google Scholar]
15. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227:680–685
    [Google Scholar]
16. Jonson G, Svennerholm A-M, Holgren J. Vibrio cholerae expresses cell surface antigens during intestinal infection which are not expressed during in vitro culture. Infect Immun 1989; 57:1809–1815
    [Google Scholar]
17. Sciortino CV, Finkelstein RA. Vibrio cholerae expresses iron-regulated outer membrane proteins in vivo. Infect Immun 1983; 42:990–996
    [Google Scholar]
18. Miller VL, Mekalanos JJ. A novel suicide vector and its use in construction of insertion mutations: Osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR. J Bacteriol 1988; 170:2575–2583
    [Google Scholar]
19. Sciortino CV. Sodium regulation of V. cholerae outer membrane proteins and enterotoxin production. In: Lambert PD. (ed) Proceedings of the 23rd US-Japan Conference on Cholera, NIAID, NIH 198796
    [Google Scholar]